<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01171014</url>
  </required_header>
  <id_info>
    <org_study_id>#08-SPUS-o6-FON-01</org_study_id>
    <nct_id>NCT01171014</nct_id>
  </id_info>
  <brief_title>Effect of Bifidobacterium Lactis HN019 on Colonic Transit Time and Digestive Symptoms</brief_title>
  <official_title>A Three-Arm, Placebo Controlled, Double-Blind, Single Center Study to Evaluate the Impact of Probiotic Strain Bifidobacterium Lactis HN019 on Intestinal Well-Being, Colonic Transit Time and Digestive Discomfort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fonterra Research Centre</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danisco</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sprim Advanced Life Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fonterra Research Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate the dose response effect of Bifidobacterium&#xD;
      lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Colonic transit time</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal symptoms</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Gastrointestinal Symptoms</condition>
  <arm_group>
    <arm_group_label>High dose probiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bifidobacterium lactis HN019, 10 billion cfu/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose probiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bifidobacterium lactis HN019, 1 billion cfu/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bifidobacterium lactis HN019</intervention_name>
    <description>Bifidobacterium lactis HN019, 10 billion cfu/day, once a day for 14 days</description>
    <arm_group_label>High dose probiotic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bifidobacterium lactis HN019</intervention_name>
    <description>Bifidobacterium lactis HN019, 1 billion cfu/day, once a day for 14 days</description>
    <arm_group_label>Low dose probiotic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo, once a day for 14 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy males and females aged 25 to 65 years&#xD;
&#xD;
          -  stool type 2-4 on the Bristol Stool Chart&#xD;
&#xD;
          -  1 to 3 bowel movements per week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  use of any probiotic product intended to improve gastrointestinal function within the&#xD;
             2 weeks preceding study entry&#xD;
&#xD;
          -  major chronic and uncontrolled systemic medical conditions&#xD;
&#xD;
          -  severe gastrointestinal conditions known to prolong CTT&#xD;
&#xD;
          -  lactose intolerance&#xD;
&#xD;
          -  chronic diarrhea&#xD;
&#xD;
          -  gastric bypass surgery or lap band insertion for weight loss&#xD;
&#xD;
          -  regular laxative use&#xD;
&#xD;
          -  pregnant or breast-feeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Waller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Accurate Clinical Research, Houston, TX</affiliation>
  </overall_official>
  <verification_date>July 2010</verification_date>
  <study_first_submitted>July 26, 2010</study_first_submitted>
  <study_first_submitted_qc>July 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2010</study_first_posted>
  <last_update_submitted>July 27, 2010</last_update_submitted>
  <last_update_submitted_qc>July 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Pramod Gopalï¼ŒPhD</name_title>
    <organization>Fonterra Research Centre</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

